• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Hyperion Therapeutics Inc

+ Add to Watchlist

HPTX:US

24.3600 USD 0.0700 0.29%

As of 20:10:00 ET on 07/21/2014.

Snapshot for Hyperion Therapeutics Inc (HPTX)

Open: 24.2700 Day's Range: 23.9000 - 24.6300 Volume: 50,364
Previous Close: 24.4300 52wk Range: 18.9740 - 32.9800 1-Yr Rtn: -7.73%

Stock Chart for HPTX

No chart data available.
  • HPTX:US 24.3900
  • 1D
  • 1M
  • 1Y
24.4300
Interactive HPTX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for HPTX

Current P/E Ratio (ttm) 74.8753
Estimated P/E(12/2014) 293.4940
Relative P/E vs. SPX 4.0976
Earnings Per Share (USD) (ttm) 0.3253
Est. EPS (USD) (12/2014) 0.0830
Est. PEG Ratio -
Market Cap (M USD) 493.64
Shares Outstanding (M) 20.26
30 Day Average Volume 141,092
Price/Book (mrq) 4.0027
Price/Sale (ttm) 8.0498
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/14/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for HPTX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for HPTX

Hyperion Therapeutics Inc. operates as a biopharmaceutical company. The Company develops therapeutics to treat disorders in the areas of orphan diseases and hepatology. Hyperion Therapeutics offers its services throughout the United States.

James I Healy "Jim"ChairmanDonald J SantelChief Executive Officer
Jeffrey S FarrowChief Financial OfficerBruce F ScharschmidtSenior VP/Chief Medical Ofcr
More Company Profile & Key Executives for HPTX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil